CN109497038A - A kind of fat saves liquid and preparation method thereof - Google Patents
A kind of fat saves liquid and preparation method thereof Download PDFInfo
- Publication number
- CN109497038A CN109497038A CN201710828614.2A CN201710828614A CN109497038A CN 109497038 A CN109497038 A CN 109497038A CN 201710828614 A CN201710828614 A CN 201710828614A CN 109497038 A CN109497038 A CN 109497038A
- Authority
- CN
- China
- Prior art keywords
- fat
- water
- saves liquid
- injection
- preservation solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
- A01N1/12—Chemical aspects of preservation
- A01N1/122—Preservation or perfusion media
- A01N1/126—Physiologically active agents, e.g. antioxidants or nutrients
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
本发明公开了一种脂肪保存液,用来保存脂肪组织样本,主要成分为高糖DMEM干粉培养基、碳酸氢钠、胰岛素、青霉素、链霉素、两性霉素、阿司匹林、维生素C、白藜芦醇、淫羊藿苷、氢化可的松、VEGF、IGF‑I、EPO。本发明脂肪保存液容易制备,成本低廉、使用方便,可长时间保持脂肪组织内干细胞的活性,大大减少了组织样本从采集到制备的时间限制,并能有效降低污染概率。The invention discloses a fat preservation solution, which is used for preserving fat tissue samples. Atrol, Icariin, Hydrocortisone, VEGF, IGF‑I, EPO. The fat preservation solution of the invention is easy to prepare, low in cost and convenient to use, can maintain the activity of stem cells in adipose tissue for a long time, greatly reduces the time limit from collection to preparation of tissue samples, and can effectively reduce the probability of contamination.
Description
技术领域technical field
本发明涉及生物技术领域,尤其涉及一种保存脂肪样本的保存液。The invention relates to the field of biotechnology, in particular to a preservation solution for preserving fat samples.
背景技术Background technique
间充质干细胞(MSCs)是一种具有多向分化潜能的干细胞,具有分化为多种中胚层细胞系的潜能,包括成骨细胞,脂肪细胞,软骨细胞等。在机体正常的损伤修复过程中,MSCs可以在趋化因子的诱导下,招募至损伤部位,在局部增殖、分化,并通过旁分泌作用参与损伤修复与组织再生。脂肪组织来源的MSCs易于分离和体外扩增,在经过多次分裂传代后仍保持多向分化潜能,是一种非常理想的细胞治疗和再生医学的种子细胞。脂肪组织分布广泛,采集容易,无伦理问题,采集基本无痛苦,且可以多次采集。Mesenchymal stem cells (MSCs) are a kind of stem cells with multi-directional differentiation potential, which have the potential to differentiate into various mesodermal cell lineages, including osteoblasts, adipocytes, chondrocytes, etc. In the normal process of injury repair in the body, MSCs can be recruited to the injury site under the induction of chemokines, proliferate and differentiate locally, and participate in injury repair and tissue regeneration through paracrine action. Adipose tissue-derived MSCs are easy to isolate and expand in vitro, and maintain multi-directional differentiation potential after multiple divisions and passages. They are ideal seed cells for cell therapy and regenerative medicine. Adipose tissue is widely distributed, easy to collect, has no ethical issues, is basically painless, and can be collected multiple times.
脂肪MSCs制备过程包括组织样本的采集、运输、交接、检测、分离、冻存、复苏、原代培养和传代培养等诸多步骤,在脂肪样本采集后到分离前需要运输、交接和检测三个步骤,实际操作中需要存放较长的时间。脂肪组织样本一旦采集,脱离了原有的体内环境,其中的MSCs的活性会受很多因素的影响,诸如时间、温度、渗透压等。目前脂肪组织样本很多情况下需要异地采集,运输、交接和检测三个步骤所用的时间就更长,组织样本需存放的时间较长,影响因素就更加的复杂。国内生物学领域对脂肪组织样本的保存多采用直接装瓶或者补加基础培养基的方法。直接装瓶脂肪组织样本的保存时间一般少于24小时,给脂肪组织样本的运输、交接和检测带来了不小的时间压力,迫切需要改进其保存方法。The preparation process of adipose MSCs includes many steps such as tissue sample collection, transportation, handover, detection, separation, cryopreservation, recovery, primary culture and subculture. Three steps of transportation, handover and detection are required after the collection of fat samples and before separation. , it needs to be stored for a long time in actual operation. Once the adipose tissue sample is collected, it is separated from the original in vivo environment, and the activity of MSCs in it will be affected by many factors, such as time, temperature, osmotic pressure and so on. At present, adipose tissue samples need to be collected from different places in many cases, and the three steps of transportation, handover and detection take longer, and the tissue samples need to be stored for a long time, and the influencing factors are more complicated. In the domestic biological field, the preservation of adipose tissue samples mostly adopts the method of direct bottling or supplementation of basal medium. The storage time of directly bottled adipose tissue samples is generally less than 24 hours, which brings considerable time pressure to the transportation, handover and detection of adipose tissue samples, and there is an urgent need to improve the storage method.
发明内容SUMMARY OF THE INVENTION
本发明的目的是为了克服现有技术中脂肪样本保存时间短、干细胞获得率和活性受影响的问题,提供了一种脂肪保存液,该脂肪保存液配比简单,成本低廉,使用方便。利用本发明脂肪保存液可以保存脂肪组织样本内干细胞的活性,在0~8℃的情况下有效保存至少120小时,分离出的干细胞活性受时间的影响很小,大大减少了组织样本从采集到制备的时间限制,并能有效降低污染概率。The purpose of the present invention is to overcome the problems of short storage time of fat samples and affected stem cell acquisition rate and activity in the prior art, and to provide a fat preservation solution with simple ratio, low cost and convenient use. The adipose preservation solution of the present invention can preserve the activity of stem cells in the adipose tissue sample, and can be effectively preserved for at least 120 hours under the condition of 0-8° C. The activity of the isolated stem cells is little affected by time, which greatly reduces the time from the collection of the tissue sample. The preparation time is limited, and the probability of contamination can be effectively reduced.
为了达到上述目的,本发明采用的技术方案是:一种脂肪保存液,每升脂肪保存液由如下成分按重量组成:高糖DMEM干粉培养基13.4g、碳酸氢钠2.438g、胰岛素2~10mg、青霉素100~200mg、链霉素100~200mg、两性霉素2.5~5mg、阿司匹林200~400mg、维生素C300~700mg、白藜芦醇7~12mg、淫羊藿苷2~10mg、氢化可的松20~40ug、VEGF 10~20μg、IGF-I 5~10μg、EPO 5~10μg,余量为注射用水。In order to achieve the above purpose, the technical scheme adopted in the present invention is: a fat preservation solution, each liter of fat preservation solution is composed of the following components by weight: 13.4g of high-sugar DMEM dry powder medium, 2.438g of sodium bicarbonate, 2-10mg of insulin , Penicillin 100~200mg, Streptomycin 100~200mg, Amphotericin 2.5~5mg, Aspirin 200~400mg, Vitamin C 300~700mg, Resveratrol 7~12mg, Icariin 2~10mg, Hydrocortisone 20~40ug, VEGF 10~20μg, IGF-I 5~10μg, EPO 5~10μg, the balance is water for injection.
上述一种脂肪保存液,其制备方法包括以下步骤:Above-mentioned a kind of fat preservation liquid, its preparation method comprises the following steps:
(1) 将高糖DMEM干粉培养基13.4g倒入一容器中,用少量注射用水将袋内残留培养基洗下,并入容器。加注射用水至950ml,轻微搅拌溶解;(1) Pour 13.4g of high-sugar DMEM dry powder medium into a container, wash off the residual medium in the bag with a small amount of water for injection, and incorporate it into the container. Add water for injection to 950ml, stir gently to dissolve;
(2) 加入2.438 g碳酸氢钠;(2) add 2.438 g sodium bicarbonate;
(3)轻微搅拌溶解,加注射用水至1L;(3) Slightly stir to dissolve, add water for injection to 1L;
(4)用1mol/L氢氧化钠溶液或者1mol/L盐酸溶液调节PH值至中性;(4) adjust pH value to neutrality with 1mol/L sodium hydroxide solution or 1mol/L hydrochloric acid solution;
(5)依次分别加入胰岛素2~10mg、青霉素100~200mg、链霉素100~200mg、两性霉素2.5~5mg、阿司匹林200~400mg、维生素C 300~700mg、白藜芦醇7~12mg、淫羊藿苷2~10mg、氢化可的松20~40ug、VEGF 10~20μg、IGF-I 5~10μg、EPO 5~10μg,充分混匀;(5) Insulin 2-10 mg, penicillin 100-200 mg, streptomycin 100-200 mg, amphotericin 2.5-5 mg, aspirin 200-400 mg, vitamin C 300-700 mg, resveratrol 7-12 mg, Carriin 2~10mg, Hydrocortisone 20~40ug, VEGF 10~20μg, IGF-I 5~10μg, EPO 5~10μg, mix well;
(6) 0.22um滤膜过滤除菌制得本发明脂肪保存液,分装,冷冻保存;使用时提前置于0~8℃解冻即可。(6) Filtration and sterilization through a 0.22um filter membrane to obtain the fat preservation solution of the present invention, which is then packaged and frozen for storage; it can be thawed at 0-8° C. in advance before use.
本发明脂肪保存液,其中高糖DMEM和碳酸氢钠是维持组织内外细胞的渗透平衡、维持PH值,保持脂肪组织湿润状态和提供营养成分;青霉素、链霉素、两性霉素可防止细菌、霉菌等污染,并可消除已发生的污染;维生素C、白藜芦醇、淫羊藿苷是抗氧化剂,可保持脂肪活性;氢化可的松抑制免疫,保护脂肪组织样本中干细胞活性;胰岛素促进脂肪对糖的吸收和利用;细胞因子如VEGF、IGF-I 、EPO,可保持增加脂肪组织中干细胞活性。The fat preservation solution of the present invention, wherein high sugar DMEM and sodium bicarbonate maintain the osmotic balance of cells inside and outside the tissue, maintain the pH value, maintain the moist state of the adipose tissue and provide nutrients; penicillin, streptomycin, and amphotericin can prevent bacteria, Mold and other pollution, and can eliminate the pollution that has occurred; vitamin C, resveratrol, icariin are antioxidants, which can maintain fat activity; hydrocortisone inhibits immunity and protects stem cell activity in adipose tissue samples; insulin promotes Absorption and utilization of sugar by fat; cytokines such as VEGF, IGF-I, EPO, can maintain and increase the activity of stem cells in adipose tissue.
本发明脂肪保存液制备简便,成本低廉、使用方便,使采集后的组织样本在运输、交接、分离前检测等过程中,能够在较长时间内有效保持其中干细胞的活性,并能防止和去除污染,提高效率。The fat preservation solution of the invention is simple to prepare, low in cost and convenient to use, so that the collected tissue samples can effectively maintain the activity of stem cells in the tissue samples for a long time during transportation, handover, detection before separation and the like, and can prevent and remove the tissue samples. pollution and improve efficiency.
具体实施方式Detailed ways
下面对本发明作进一步详细说明。The present invention will be described in further detail below.
实施例一Example 1
本发明提供的一种脂肪保存液,每升脂肪保存液由如下成分按重量组成:高糖DMEM干粉培养基13.4g、碳酸氢钠2.438g、胰岛素10mg、青霉素200mg、链霉素200mg、两性霉素5mg、阿司匹林400mg、维生素C 700mg、白藜芦醇 12mg、淫羊藿苷 10mg、氢化可的松 40ug、VEGF20μg、IGF-I 10μg、EPO 10μg,余量为注射用水。The fat preservation solution provided by the present invention is composed of the following components by weight per liter of fat preservation solution: 13.4 g of high-sugar DMEM dry powder medium, 2.438 g of sodium bicarbonate, 10 mg of insulin, 200 mg of penicillin, 200 mg of streptomycin, 200 mg of amphotericin Vitamin C 5mg, Aspirin 400mg, Vitamin C 700mg, Resveratrol 12mg, Icariin 10mg, Hydrocortisone 40ug, VEGF 20μg, IGF-I 10μg, EPO 10μg, the balance is water for injection.
该脂肪保存液的制备方法如下:The preparation method of the fat preservation solution is as follows:
(1) 将高糖DMEM干粉培养基(品牌:GIBCO,货号12100-046)13.4g倒入一容器中,用少量注射用水将袋内残留培养基洗下,并入容器。加注射用水至950ml,轻微搅拌溶解;(1) Pour 13.4g of high-sugar DMEM dry powder medium (brand: GIBCO, product number 12100-046) into a container, wash the residual medium in the bag with a small amount of water for injection, and incorporate it into the container. Add water for injection to 950ml, stir gently to dissolve;
(2) 加入2.438 g碳酸氢钠;(2) add 2.438 g sodium bicarbonate;
(3)轻微搅拌溶解,加注射用水至1L;(3) Slightly stir to dissolve, add water for injection to 1L;
(4)用1mol/L氢氧化钠溶液或者1mol/L盐酸溶液调节PH值至中性;(4) adjust pH value to neutrality with 1mol/L sodium hydroxide solution or 1mol/L hydrochloric acid solution;
(5)依次分别加入胰岛素10mg(品牌Sigma, 货号I0908)、青霉素200mg(品牌Amresco,货号0242)、链霉素200mg(品牌Amresco,货号0382)、两性霉素5mg(品牌Amresco,货号E437)、阿司匹林400mg(Sigma,A2093-100G)、维生素C 700mg(Sigma,A5960-10mg)、白藜芦醇12mg(Sigma, R5010-100MG)、淫羊藿苷10mg(上海微晶生物, 489-32-7,20mg)、氢化可的松 40ug(Sigma, H3160)、VEGF 20μg(PeproTech,96-100-20-2)、IGF-I 10μg(PeproTech,96-100-11-20)、EPO 10μg(PeproTech ,CYT-201),充分混匀;(5) Insulin 10mg (brand Sigma, product number I0908), penicillin 200mg (brand Amresco, product number 0242), streptomycin 200mg (brand Amresco, product number 0382), amphotericin 5mg (brand Amresco, product number E437), Aspirin 400mg (Sigma, A2093-100G), Vitamin C 700mg (Sigma, A5960-10mg), Resveratrol 12mg (Sigma, R5010-100MG), Icariin 10mg (Shanghai Microcrystalline Bio, 489-32-7 , 20mg), hydrocortisone 40ug (Sigma, H3160), VEGF 20μg (PeproTech, 96-100-20-2), IGF-I 10μg (PeproTech, 96-100-11-20), EPO 10μg (PeproTech, CYT-201), mix well;
(6) 0.22um滤膜过滤除菌,制得脂肪保存液,分装,冷冻保存;使用时提前置于0~8℃解冻即可。(6) Filter and sterilize with a 0.22um filter membrane to obtain a fat preservation solution, which is then packaged and frozen for storage; it can be thawed in advance at 0~8°C before use.
实施例二Embodiment 2
本发明提供的一种脂肪保存液,每升脂肪保存液由如下成分按重量组成:高糖DMEM干粉培养基13.4g、碳酸氢钠2.438g、胰岛素2mg、青霉素100mg、链霉素100mg、两性霉素2.5mg、阿司匹林200mg、维生素C 300mg、白藜芦醇 7mg、淫羊藿苷 2mg、氢化可的松 20ug、VEGF 10μg、IGF-I 5μg、EPO 5μg,余量为注射用水。A fat preservation solution provided by the present invention is composed of the following components by weight per liter of fat preservation solution: 13.4 g of high-sugar DMEM dry powder medium, 2.438 g of sodium bicarbonate, 2 mg of insulin, 100 mg of penicillin, 100 mg of streptomycin, 100 mg of amphotericin Vitamin C 2.5mg, aspirin 200mg, vitamin C 300mg, resveratrol 7mg, icariin 2mg, hydrocortisone 20ug, VEGF 10μg, IGF-I 5μg, EPO 5μg, the balance is water for injection.
该脂肪保存液的制备方法如下:The preparation method of the fat preservation solution is as follows:
(1) 将高糖DMEM干粉培养基 13.4g倒入一容器中,用少量注射用水将袋内残留培养基洗下,并入容器。加注射用水至950ml,轻微搅拌溶解;(1) Pour 13.4g of high-sugar DMEM dry powder medium into a container, wash the residual medium in the bag with a small amount of water for injection, and put it into the container. Add water for injection to 950ml, stir gently to dissolve;
(2) 加入2.438 g碳酸氢钠;(2) add 2.438 g sodium bicarbonate;
(3)轻微搅拌溶解,加注射用水至1L;(3) Slightly stir to dissolve, add water for injection to 1L;
(4)用1mol/L氢氧化钠溶液或者1mol/L盐酸溶液调节PH值至中性;(4) adjust pH value to neutrality with 1mol/L sodium hydroxide solution or 1mol/L hydrochloric acid solution;
(5)依次分别加入胰岛素2mg、青霉素100mg、链霉素100mg、两性霉素2.5mg、阿司匹林200mg、维生素C 300mg、白藜芦醇 7mg、淫羊藿苷 2mg、氢化可的松 20ug、VEGF 10μg、IGF-I5μg、EPO 5μg,充分混匀;(5) Insulin 2mg, penicillin 100mg, streptomycin 100mg, amphotericin 2.5mg, aspirin 200mg, vitamin C 300mg, resveratrol 7mg, icariin 2mg, hydrocortisone 20ug, VEGF 10μg were added in sequence , IGF-I 5μg, EPO 5μg, mix well;
(6) 0.22um滤膜过滤除菌,分装,冷冻保存,制得脂肪保存液;使用时提前置于0~8℃解冻即可。(6) Filter and sterilize with a 0.22um filter membrane, sub-pack, freeze and store to obtain a fat preservation solution; thaw at 0~8°C in advance before use.
实施例三Embodiment 3
本发明提供的一种脂肪保存液,每升脂肪保存液由如下成分按重量组成:高糖DMEM干粉培养基13.4g、碳酸氢钠2.438g、胰岛素5mg、青霉素150mg、链霉素150mg、两性霉素4mg、阿司匹林300mg、维生素C 400mg、白藜芦醇 8mg、淫羊藿苷 3mg、氢化可的松 30ug、VEGF 15μg、IGF-I 6μg、EPO 6μg,余量为注射用水。A fat preservation solution provided by the present invention, each liter of fat preservation solution is composed of the following components by weight: high-sugar DMEM dry powder medium 13.4g, sodium bicarbonate 2.438g, insulin 5mg, penicillin 150mg, streptomycin 150mg, amphoteric mold Vitamin C 4mg, Aspirin 300mg, Vitamin C 400mg, Resveratrol 8mg, Icariin 3mg, Hydrocortisone 30ug, VEGF 15μg, IGF-I 6μg, EPO 6μg, the balance is water for injection.
该脂肪保存液的制备方法如下:The preparation method of the fat preservation solution is as follows:
(1) 将高糖DMEM干粉培养基13.4g倒入一容器中,用少量注射用水将袋内残留培养基洗下,并入容器。加注射用水至950ml,轻微搅拌溶解;(1) Pour 13.4g of high-sugar DMEM dry powder medium into a container, wash off the residual medium in the bag with a small amount of water for injection, and incorporate it into the container. Add water for injection to 950ml, stir gently to dissolve;
(2) 加入2.438 g碳酸氢钠;(2) add 2.438 g sodium bicarbonate;
(3)轻微搅拌溶解,加注射用水至1L;(3) Slightly stir to dissolve, add water for injection to 1L;
(4)用1mol/L氢氧化钠溶液或者1mol/L盐酸溶液调节PH值至中性;(4) adjust pH value to neutrality with 1mol/L sodium hydroxide solution or 1mol/L hydrochloric acid solution;
(5)依次分别加入胰岛素5mg、青霉素150mg、链霉素150mg、两性霉素4mg、阿司匹林300mg、维生素C 400mg、白藜芦醇 8mg、淫羊藿苷 3mg、氢化可的松 30ug、VEGF 15μg、IGF-I6μg、EPO 6μg,充分混匀;(5) Insulin 5mg, penicillin 150mg, streptomycin 150mg, amphotericin 4mg, aspirin 300mg, vitamin C 400mg, resveratrol 8mg, icariin 3mg, hydrocortisone 30ug, VEGF 15μg, IGF-I 6μg, EPO 6μg, mix well;
(6) 0.22um滤膜过滤除菌制得脂肪保存液,分装,冷冻保存;使用时提前置于0~8℃解冻即可。(6) Filtration and sterilization of 0.22um filter membrane to obtain fat preservation solution, subpackage, and cryopreservation; it can be thawed at 0~8℃ in advance before use.
实施例四Embodiment 4
脂肪组织的采集及保存:用本发明的脂肪保存液保存吸脂后到分离前的人脂肪组织,即无菌采集脂肪后,吸弃膨胀液,将采集的脂肪组织放入装有本发明的脂肪保存液的脂肪采集瓶中,拧紧瓶盖并密封,放入恒温箱中0~8℃恒温保存至分离。Collection and preservation of adipose tissue: use the fat preservation solution of the present invention to preserve the human adipose tissue after liposuction and before separation, that is, after aseptically collecting fat, aspirating and discarding the swelling fluid, and placing the collected adipose tissue into a adipose tissue containing the present invention. In the fat collection bottle of the fat preservation solution, tighten the bottle cap and seal it, and put it in an incubator at 0~8°C for constant temperature preservation until separation.
保存液的保存效果对比:将采集的脂肪组织均分为5份,分别保存在本发明的脂肪保存液、磷酸盐缓冲液PBS、生理盐水和高糖DMEM培养基(液体)中,最后一份直接将脂肪组织单独放置,在0~8℃恒温保存24小时、48小时、72小时、120小时后胶原酶消化分离,取相同克数脂肪组织块分离获得的有核细胞常规培养9天后,消化计数。同时留一份新鲜脂肪组织不保存作为对照,直接胶原酶消化分离后取相同克数脂肪组织块获得的有核细胞常规培养9天,消化后计数为6.20×107。Comparison of the preservation effect of the preservation solution: the collected adipose tissue is divided into 5 parts, and they are respectively stored in the fat preservation solution of the present invention, phosphate buffered saline PBS, physiological saline and high-glucose DMEM medium (liquid). The adipose tissue was directly placed alone, stored at a constant temperature of 0~8°C for 24 hours, 48 hours, 72 hours, and 120 hours, and then digested and separated by collagenase. The nucleated cells obtained by taking the same grams of adipose tissue blocks were routinely cultured for 9 days, and then digested. count. At the same time, a portion of fresh adipose tissue was not preserved as a control, and the nucleated cells obtained from the same gram of adipose tissue block after direct collagenase digestion and separation were routinely cultured for 9 days, and the count after digestion was 6.20×10 7 .
保存结果显示如下:The save result is displayed as follows:
对过去一年脂肪采集运输进行污染率统计,不加任何溶液保存的脂肪组织64份中有2份污染,污染率为3.1%;经本发明脂肪保存液保存的371份脂肪组织中没有一份污染,污染率为0。Contamination rate statistics for fat collection and transportation in the past year, 2 out of 64 adipose tissues stored without any solution were contaminated, with a contamination rate of 3.1%; none of the 371 adipose tissues preserved by the fat preservation solution of the present invention pollution, the pollution rate is 0.
可以看出,本发明的脂肪保存液,可以使采集后的组织样本在运输、交接、分离前检测等过程中,能够在较长时间内(超过5天)有效保持其中干细胞的活性,提高干细胞得率,并能防止和去除污染,扩大了组织样本库干细胞存储的业务范围。It can be seen that the fat preservation solution of the present invention can effectively maintain the activity of stem cells in the collected tissue samples for a long time (more than 5 days) in the process of transportation, handover, detection before separation, etc. Yield, and can prevent and remove contamination, expanding the business scope of tissue sample bank stem cell storage.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710828614.2A CN109497038A (en) | 2017-09-14 | 2017-09-14 | A kind of fat saves liquid and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710828614.2A CN109497038A (en) | 2017-09-14 | 2017-09-14 | A kind of fat saves liquid and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109497038A true CN109497038A (en) | 2019-03-22 |
Family
ID=65744826
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710828614.2A Pending CN109497038A (en) | 2017-09-14 | 2017-09-14 | A kind of fat saves liquid and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109497038A (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110663679A (en) * | 2019-10-24 | 2020-01-10 | 青岛瑞思德生物科技有限公司 | A kind of placenta preservation solution and preparation method thereof |
CN113303326A (en) * | 2021-05-28 | 2021-08-27 | 吉林大学第一医院 | Organ preservation solution and liver in-vitro preservation method |
CN113841688A (en) * | 2021-11-06 | 2021-12-28 | 马高辉 | A kind of preservation solution and cell bank construction method for constructing bone marrow mesenchymal stem cell bank |
CN113925049A (en) * | 2021-12-17 | 2022-01-14 | 广东乾晖生物科技有限公司 | Cell preservation solution for maintaining cell activity and preparation method and application thereof |
CN114568422A (en) * | 2020-11-30 | 2022-06-03 | 北京瑷格干细胞科技有限公司 | Fat preservation liquid and application thereof |
CN114651812A (en) * | 2022-02-22 | 2022-06-24 | 杨明 | A kind of adipose mesenchymal stem cell cryopreservation protection solution and cryopreservation method |
CN115851589A (en) * | 2022-12-22 | 2023-03-28 | 青岛瑞思德生物科技有限公司 | Efficient preparation kit for umbilical cord mesenchymal stem cells |
WO2023061450A1 (en) * | 2021-10-13 | 2023-04-20 | 无锡赛比曼生物科技有限公司 | Adipose tissue transport preservation solution |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101210232A (en) * | 2006-12-28 | 2008-07-02 | 天津昂赛细胞基因工程有限公司 | Mesenchyme stem cell preserving fluid and use thereof |
CN101790306A (en) * | 2007-02-17 | 2010-07-28 | 哈佛学院董事会 | Compositions and method for tissue preservation |
CA2762584A1 (en) * | 2009-05-20 | 2010-11-25 | Cardio3 Biosciences S.A. | Pharmaceutical composition for the treatment of heart diseases |
CN104396940A (en) * | 2014-10-11 | 2015-03-11 | 张炳强 | Tissue sample preservative solution and preparation method thereof |
CN105820998A (en) * | 2016-03-30 | 2016-08-03 | 王凌仪 | Isolation extraction and culture method for human adipose-derived stem cells (ADSCs) for clinical back-transfusion grade cell therapy |
-
2017
- 2017-09-14 CN CN201710828614.2A patent/CN109497038A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101210232A (en) * | 2006-12-28 | 2008-07-02 | 天津昂赛细胞基因工程有限公司 | Mesenchyme stem cell preserving fluid and use thereof |
CN101790306A (en) * | 2007-02-17 | 2010-07-28 | 哈佛学院董事会 | Compositions and method for tissue preservation |
CA2762584A1 (en) * | 2009-05-20 | 2010-11-25 | Cardio3 Biosciences S.A. | Pharmaceutical composition for the treatment of heart diseases |
CN104396940A (en) * | 2014-10-11 | 2015-03-11 | 张炳强 | Tissue sample preservative solution and preparation method thereof |
CN105820998A (en) * | 2016-03-30 | 2016-08-03 | 王凌仪 | Isolation extraction and culture method for human adipose-derived stem cells (ADSCs) for clinical back-transfusion grade cell therapy |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110663679A (en) * | 2019-10-24 | 2020-01-10 | 青岛瑞思德生物科技有限公司 | A kind of placenta preservation solution and preparation method thereof |
CN114568422A (en) * | 2020-11-30 | 2022-06-03 | 北京瑷格干细胞科技有限公司 | Fat preservation liquid and application thereof |
CN113303326A (en) * | 2021-05-28 | 2021-08-27 | 吉林大学第一医院 | Organ preservation solution and liver in-vitro preservation method |
WO2023061450A1 (en) * | 2021-10-13 | 2023-04-20 | 无锡赛比曼生物科技有限公司 | Adipose tissue transport preservation solution |
CN113841688A (en) * | 2021-11-06 | 2021-12-28 | 马高辉 | A kind of preservation solution and cell bank construction method for constructing bone marrow mesenchymal stem cell bank |
CN113925049A (en) * | 2021-12-17 | 2022-01-14 | 广东乾晖生物科技有限公司 | Cell preservation solution for maintaining cell activity and preparation method and application thereof |
CN113925049B (en) * | 2021-12-17 | 2022-04-29 | 广东乾晖生物科技有限公司 | Cell preservation solution for maintaining cell activity and preparation method and application thereof |
CN114651812A (en) * | 2022-02-22 | 2022-06-24 | 杨明 | A kind of adipose mesenchymal stem cell cryopreservation protection solution and cryopreservation method |
CN115851589A (en) * | 2022-12-22 | 2023-03-28 | 青岛瑞思德生物科技有限公司 | Efficient preparation kit for umbilical cord mesenchymal stem cells |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109497038A (en) | A kind of fat saves liquid and preparation method thereof | |
CN104396940B (en) | A kind of tissue samples preserves liquid and preparation method thereof | |
CN106465710B (en) | Adipose tissue cryopreservation solution and adipose tissue cryopreservation method | |
AU2002326901A1 (en) | Preservation of non embryonic cells from non hematopoietic tissues | |
EP1427279A1 (en) | Preservation of non embryonic cells from non hematopoietic tissues | |
CN101381676B (en) | Apparatus and method for in situ cryopreservation of three-dimensional scaffold culture of adherent cells | |
CN106754639B (en) | Large-scale preparation method of mesenchymal stem cell factor | |
CN101974484A (en) | Method for preparing human umbilical cord mesenchymal stem cells | |
WO2009052132A1 (en) | Human amniotic fluid derived mesenchymal stem cells | |
CN112458040B (en) | A method for isolating and culturing adult yak rumen epithelial cells | |
CN102660502A (en) | Methods for freezing and thawing whole cell of umbilical cord and separating and augmenting stem cell | |
WO2017214146A1 (en) | Cvs transplantation for treatment of bacterial vaginosis | |
CN108056095A (en) | A kind of fat mesenchymal stem cell transport protection liquid and its application | |
CN108524601A (en) | A kind of vaginal jellies and preparation method thereof containing pleiotrophic factor | |
IL298107B1 (en) | Compounds containing stem cells derived from adipose tissue for use in the treatment of recurrent symptoms of complex rectal abscesses in Crohn's disease | |
CN104983742A (en) | Stem cell preparation for treating degenerative osteoarthropathy and preparation method of stem cell preparation | |
CN106309491A (en) | Application of menstrual blood stem cells in preparation of drugs for treating intrauterine adhesion | |
CN108642002A (en) | A kind of method of serum-free domestication culture human mesenchymal stem cell | |
CN106386782A (en) | An umbilical cord preserving fluid | |
CN107502588A (en) | A kind of method that separation prepares dental pulp stem cell | |
CN113842398B (en) | Umbilical mesenchymal stem cell external gel for promoting wound healing, and administration method and application thereof | |
CN109182263A (en) | A method of palace film mescenchymal stem cell is separated with Tea Saponin dissolution menstruation erythrocyte | |
CN111494615A (en) | Method for producing recombinant adenovirus gene vaccine for preventing novel coronavirus | |
CN106668855B (en) | Mycoplasma hyopneumoniae inactivated vaccine and classical swine fever live vaccine combined vaccine and preparation method thereof | |
CN107090434B (en) | Blood anticoagulation and preservation method for improving CIK cell culture effect |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20190322 |
|
WD01 | Invention patent application deemed withdrawn after publication |